HILL DERMACEUTICALS, INC.
HILL DERMACEUTICALS, INC. lists 1 drug product in the FDA National Drug Code directory.
Products
Recalls by HILL DERMACEUTICALS, INC.
- D-0637-2021 Jun 30, 2021 · Class II
Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper. - D-1181-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1180-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1179-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1178-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1177-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1176-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1175-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1174-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-1173-2014 Apr 2, 2014 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-008-2014 Nov 27, 2013 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-007-2014 Nov 27, 2013 · Class III
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-610-2013 Jul 3, 2013 · Class III
Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing. - D-218-2013 Apr 3, 2013 · Class III
Subpotent; 22 month stability timepoint - D-217-2013 Apr 3, 2013 · Class III
Subpotent; 12 month stability timepoint - D-1647-2012 Aug 22, 2012 · Class III
Subpotent; fluocinolone acetonide - D-1646-2012 Aug 22, 2012 · Class III
Subpotent; fluocinolone acetonide